Original BioMedicals Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 0.043 million compared to TWD 0.107 million a year ago. Net loss was TWD 59.66 million compared to TWD 40.28 million a year ago.

Basic loss per share from continuing operations was TWD 1.21 compared to TWD 0.86 a year ago. Diluted loss per share from continuing operations was TWD 1.21 compared to TWD 0.86 a year ago.